gemcitabine has been researched along with Signet Ring Cell Carcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Ishii, M; Kawamura, N; Nagahara, A; Nakai, Y; Nakayama, M; Nishimura, K; Yamamoto, Y; Yoshimura, A | 1 |
| Ilic, D; Ilic, I; Radojkovic, M | 1 |
| El-Baradie, M; Ismail, HM; Khorshid, O; Moneer, M; Touny, A | 1 |
| Arranz, EM; Arranz, MD; Bellido, EC; Cabral, JM; García, AB; Juberías, LA; Kreilinger, JJ; Parga, JM; Prianes, LA; Robledo, JP; Sanz, RR; Sanz-Agero, PG; Serrano, EM | 1 |
| Bustamante-Montalvo, M; Fernández-Pérez, A; Lesquereux-Martínez, L | 1 |
| Boutry, N; Brénuchon, C; Devulder, B; Hachulla, E; Hatron, PY; Lambert, M; Launay, D; Maurage, CA; N'Guyen, HD; Queyrel, V | 1 |
| Chow, KU; Engels, K; Kim, SZ; Kriener, S; Mitrou, PS; Trojan, J | 1 |
2 review(s) available for gemcitabine and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Primary signet ring cell carcinoma of the pancreas with a good response to chemotherapy: case report and literature review.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Pancreaticoduodenectomy; Prognosis | 2017 |
[Signet ring cell carcinoma of the ampulla of Vater].
Topics: Aged; Ampulla of Vater; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cholangiopancreatography, Endoscopic Retrograde; Combined Modality Therapy; Common Bile Duct Neoplasms; Deoxycytidine; Gemcitabine; Humans; Jaundice, Obstructive; Jejunum; Liver; Lymphoma, Follicular; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pancreatectomy; Pancreaticoduodenectomy; Splenectomy; Urinary Bladder Neoplasms | 2011 |
1 trial(s) available for gemcitabine and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Deoxycytidine; Disease Progression; Female; Follow-Up Studies; Gastrectomy; Gemcitabine; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Receptor, ErbB-2; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tissue Array Analysis; Treatment Outcome; Tumor Suppressor Protein p53; Young Adult | 2007 |
4 other study(ies) available for gemcitabine and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
[A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Female; Gemcitabine; Humans; Middle Aged; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |
Signet ring cell adenocarcinoma of the ampulla of Vater: a rare pathology.
Topics: Aged; Ampulla of Vater; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Common Bile Duct Neoplasms; Deoxycytidine; Diagnostic Imaging; Female; Gemcitabine; Humans; Lymphatic Metastasis; Pancreaticoduodenectomy | 2012 |
[Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].
Topics: Adrenal Cortex Hormones; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Carcinoma, Signet Ring Cell; Deoxycytidine; Gemcitabine; Humans; Hypertrophy; Male; Muscle Neoplasms; Muscle, Skeletal; Muscular Diseases; Neoplasm Recurrence, Local; Thigh; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Deoxycytidine; Diphosphonates; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Imidazoles; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Remission Induction; Stomach Neoplasms; Tumor Cells, Cultured; Zoledronic Acid | 2005 |